Dr. Jan Paolo P. Dipasupil, MD Lifestyle Medicine · Obesity Medicine Founder & CEO, Jan Medical Group Head, Lifestyle Medicine — The Medical City Wellness and Aesthetics Institute (Pasig City) VP, Philippine Digital Medicine Society (PDMS) Jan Medical Group (JMG) is a physician-led clinic with branches in BGC (Taguig) and Quezon City (Brgy. Manresa). We go beyond the number on the scale — addressing the full clinical picture of metabolic health, body composition, and the physical consequences of weight loss. Weight Challenges We Treat Overweight and obesity in adults. Adolescent obesity with age-appropriate, family-centered medical management. Sarcopenic obesity — excess fat with concurrent muscle loss. Weight plateau, including post-extreme diet, OMAD, and crash program rebound. Post-GLP-1 body recomposition. PCOS and hormonal weight gain. Night shift and BPO-related metabolic disruption. Emotional eating and craving dysregulation. Fatty liver, elevated SGPT, and metabolic syndrome. Medical Weight Management Pharmacotherapy is one tool within a physician-supervised, individually designed program — never a standalone solution. Currently available: Semaglutide (Ozempic, Wegovy), Tirzepatide (Mounjaro, Zepbound), Phentermine (Duromine), Phentermine + Topiramate (Qsymia), and Naltrexone + Bupropion (Contrave). Pipeline medications not yet locally available — we counsel patients preparing for these: oral semaglutide (Wegovy oral), and orforglipron (Foundera), an oral non-peptide GLP-1 agonist. All pharmacotherapy is preceded by metabolic workup and body composition analysis (InBody/Styku). The Consequences of Weight Loss We Address Significant weight loss — especially rapid or medication-assisted — frequently produces physical consequences that most clinics overlook. We systematically identify and treat: gaunt face and facial volume loss (commonly called “GLP-1 face,” with hollowing of the cheeks, temples, and midface); loose skin and skin laxity from collagen breakdown after rapid fat loss; stretch marks from dermal stress during rapid volume shifts; muscle loss (sarcopenia) from caloric restriction without adequate protein or resistance training; slow metabolism from adaptive thermogenesis post-diet; hormone imbalance involving disrupted leptin, ghrelin, cortisol, and thyroid function; hair loss (telogen effluvium) triggered by physiological stress; and persistent cravings driven by neurohormonal appetite resurgence after weight loss. Non-Invasive Treatments Emsculpt NEO (BGC only) — combines HIFEM+ and radiofrequency in a single session to simultaneously reduce fat and build muscle. Average 30% fat reduction and up to 25% muscle increase. Core treatment for sarcopenic obesity and post-GLP-1 muscle loss. EMFACE (BGC only) — synchronized RF and HIFEM for the face. Lifts facial muscles, tightens skin, and restores facial definition. Primary treatment for GLP-1 face and post-weight loss facial laxity. No needles, no downtime. EXION (BGC only) — monopolar RF with AI-guided ultrasound for deep collagen and hyaluronic acid stimulation. Treats loose skin, stretch marks, and body laxity after fat loss. Includes EXION Femme Inner for intimate wellness and pelvic floor support. EXOMIND (BGC only) — electromagnetic brain stimulation for cognitive performance, stress regulation, and burnout recovery. Addresses the neurological and emotional drivers of metabolic dysregulation. Exilis Ultra 360 (QC only) — radiofrequency and focused ultrasound for skin tightening and body contouring of the arms, abdomen, neck, and jawline. Clinic Locations BGC Branch — Taguig City. Treatments: EMFACE, EXION, EXOMIND, Emsculpt NEO. Corporate wellness flagship. QC Branch — Brgy. Manresa, Quezon City. Treatments: Exilis Ultra 360.